TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
TiumBio Co Ltd
Total Liabilities
TiumBio Co Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
Total Liabilities
₩54.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
125%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Total Liabilities
₩5.1T
|
CAGR 3-Years
43%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Total Liabilities
₩1.2T
|
CAGR 3-Years
43%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Liabilities
₩7.2B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Liabilities
₩253.5B
|
CAGR 3-Years
38%
|
CAGR 5-Years
55%
|
CAGR 10-Years
77%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Liabilities
₩126.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
TiumBio Co Ltd
Glance View
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.
See Also
What is TiumBio Co Ltd's Total Liabilities?
Total Liabilities
54.8B
KRW
Based on the financial report for Dec 31, 2024, TiumBio Co Ltd's Total Liabilities amounts to 54.8B KRW.
What is TiumBio Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
125%
Over the last year, the Total Liabilities growth was 11%. The average annual Total Liabilities growth rates for TiumBio Co Ltd have been 23% over the past three years , 125% over the past five years .
